Microbot Medical Inc MBOT 深 沪
已收盘 07-02 16:00:00 美东时间
1.91
0.000
0.00%
华盛通- 最 高1.98
- 今 开1.92
- 成交量 77.45万股
- 最 低 1.87
- 昨 收 1.91
- 总市值 1.28亿
- 52周最高 4.67
- 市盈率 静 --
- 换手率 1.15%
- 52周最低 1.6001
- 委 比 -95.15%
- 总股本 6716.48万
- 历史最高 149.10
- 量 比 0.76
- 振 幅 5.76%
- 历史最低 0.82
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal healthcare systems, such as those administered by the Veterans Health Administration (VHA), a divisi...
06-16 20:38
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
06-04 01:51
Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel becomes the second
05-26 20:32
Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co
https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-medicals-liberty-endovascular-robotic-system-and-its-clear-that-it-will-be-a-commercial-failure-1-price-target/
05-14 21:37
Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates
Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practiceThe Company will attend the Annual Global Embolization
05-05 20:38
美股大行评级 | 小摩上调Bloom Energy目标价从166美元升至231美元；目标价28美元！大摩、高盛等多家机构首予Janus Living(JAN)超配评级
今日重点评级关注：Ascendiant Capital：维持Banzai International"买入"评级，目标价从23美元升至24美元；Ascendiant Capital：维持Synergy CHC Corp."买入"评级，目标价从5美元升至5.5美元
04-15 11:31
Microbot Medical Entered ATM Agreement With H.C. Wainwright & Co; May Offer & Sell Up To $39.2M
-SEC Filing
04-11 05:36
Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate
Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of $(0.19) per share from
03-27 05:47
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
Emory Healthcare successfully performed robotic prostate artery embolization (PAE) and Y-90 radioembolization for liver cancer using Microbot Medical's LIBERTY System, a first-of-its-kind FDA-cleared, single-use robotic platform. The system enhances precision, efficiency, and safety in minimally invasive endovascular procedures, addressing conditions like benign prostatic hyperplasia (BPH) and liver cancer.
03-26 12:30
